netFormulary NHS
Lancashire and South Cumbria
Formulary
 Search
 Formulary Chapter 2: Cardiovascular system - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
02.01.01 Cardiac glycosides (2,0)
Digoxin-specific antibody (1,0)
02.01.02 Phosphodiesterase type-3 inhibitors (2,0)
02.02.01 Thiazides and related diuretics (3,0)
02.02.02 Loop diuretics (3,0)
02.02.03 Potassium-sparing diuretics and aldosterone antagonists (1,0)
Aldosterone antagonists (3,0)
02.02.04 Potassium-sparing diuretics with other diuretics (1,0)
02.02.05 Osmotic diuretics (1,0)
02.03.02 Drugs for arrhythmias (1,0)
Supraventricular arrhythmias (2,0)
Supraventricular and ventricular arrhythmias (6,0)
Ventricular arrhythmias (2,0)
02.04 Beta-adrenoceptor blocking drugs (12,0)
02.05 Drugs affecting the renin-angiotensin system and some other antihypertensive drugs (0,0)
02.05.01 Vasodilator antihypertensive drugs (5,0)
02.05.02 Centrally acting antihypertensive drugs (3,0)
02.05.04 Alpha-adrenoceptor blocking drugs (1,0)
Phaeochromocytoma (2,0)
02.05.05 Drugs affecting the renin-angiotensin system (0,0)
Heart Failure (2,0)
02.05.05.01 Angiotensin-converting enzyme inhibitors (ACE inhibitors) (4,0)
02.05.05.02 Angiotensin-II receptor antagonists (5,0)
02.05.05.03 Renin inhibitors (1,0)
02.06.01 Nitrates (3,0)
02.06.02 Calcium-channel blockers (9,0)
02.06.03 Other anitanginal drugs (3,0)
02.06.04 Peripheral vasodilators and related drugs (8,0)
02.07.01 Inotropic sympathomimetics (3,0)
02.07.02 Vasoconstrictor sympathomimetics (4,0)
02.07.03 Cardiopulmonary resuscitation (1,0)
02.08.01 Parenteral anticoagulants (1,0)
Heparin (1,0)
Low molecular weight heparins (3,0)
Heparinoids (1,0)
Heparin flushes (1,0)
Epoprostenol (1,0)
Fondaparinux (2,0)
02.08.02 Oral anticoagulants (9,0)
02.08.03 Protamine sulphate (1,0)
02.09 Antiplatelet drugs (6,0)
02.10.02 Fibrinolytic drugs (4,0)
02.11 Antifibrinolytic drugs and haemostatics (2,0)
02.12 Lipid-regulating drugs (0,0)
Statins (5,0)
Bile acid sequestrants (2,0)
Ezetimibe (1,0)
Fibrates (2,0)
PCSK9 inhibitors (3,0)
Other lipid modifying agents (5,0)
02.13 Local sclerosants (1,0)
netFormulary